Improving pharmaceutical-sector financing in low- and middle-income countries (LMICs) is essential to ensuring universal access to pharmaceutical products and services. In many LMICs, pharmaceuticals are primarily […]
Read MoreMTaPS conducted a Political Economy Analysis in Uganda to examine the factors that influence domestic financing of FP products and associated supply chain costs that may […]
Read MoreTo enhance appropriate use of limited resources, policymakers need to know where resources for pharmaceuticals come from; how much is spent within a given period; what […]
Read More